Australia - English - Department of Health (Therapeutic Goods Administration)

atnahs pharma australia pty ltd - famciclovir, quantity: 250 mg - tablet, film coated - excipient ingredients: magnesium stearate; hyprolose; lactose; sodium starch glycollate; titanium dioxide; hypromellose; macrogol 6000; macrogol 4000 - elovax is indicated for the treatment of herpes zoster infection in adult patients who commence therapy within 72 hours of the onset of the rash. greatest benefit occurs if the drug is started within 48 hours. efficacy has not been demonstrated in patients less than 50 years of age, although the occasional younger patient with severe herpes zoster may benefit from therapy with famciclovir. herpes zoster is generally a milder condition in younger patients. elovax is also indicated in the treatment of recurrent episodes of genital herpes in adults and adolescents 12 years of age and older. elovax is also indicated for suppression of recurrent genital herpes. elovax is also indicated for the treatment of recurrent herpes labialis (cold sores) in immunocompetent patients elovax is also indicated in immunocompromised patients for: treatment of uncomplicated herpes zoster; treatment of recurrent herpes simplex; suppression of recurrent herpes simplex.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - famciclovir, quantity: 500 mg - tablet, film coated - excipient ingredients: titanium dioxide; hyprolose; magnesium stearate; hypromellose; lactose; sodium starch glycollate type a; macrogol 400 - famciclovir is indicated for the treatment of herpes zoster infection in adult patients who commence therapy within 72 hours of the onset of rash. greatest benefit occurs if the drug is started within 48 hours. efficacy has not been demonstrated in patients less than 50 years of age, although the occasional younger patient with severe herpes zoster may benefit from therapy with famciclovir. herpes zoster infection is generally a milder condition in younger patients. famciclovir is also indicated for the treatment of recurrent episodes of genital herpes in adults and adolescents 12 years of age and older. famciclovir is also indicated for suppression of recurrent genital herpes. famciclovir is also indicated in immunocompromised patients for:- treatment of uncomplicated herpes zoster, - treatment of recurrent herpes simplex, - suppression of recurrent herpes simplex

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - famciclovir, quantity: 250 mg - tablet, film coated - excipient ingredients: titanium dioxide; sodium starch glycollate type a; hypromellose; hyprolose; magnesium stearate; lactose; macrogol 400 - famciclovir is indicated for the treatment of herpes zoster infection in adult patients who commence therapy within 72 hours of the onset of rash. greatest benefit occurs if the drug is started within 48 hours. efficacy has not been demonstrated in patients less than 50 years of age, although the occasional younger patient with severe herpes zoster may benefit from therapy with famciclovir. herpes zoster infection is generally a milder condition in younger patients. famciclovir is also indicated for the treatment of recurrent episodes of genital herpes in adults and adolescents 12 years of age and older. famciclovir is also indicated for suppression of recurrent genital herpes. famciclovir is also indicated in immunocompromised patients for:- treatment of uncomplicated herpes zoster, - treatment of recurrent herpes simplex, - suppression of recurrent herpes simplex

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - famciclovir, quantity: 125 mg - tablet, film coated - excipient ingredients: hyprolose; titanium dioxide; sodium starch glycollate type a; lactose; macrogol 400; hypromellose; magnesium stearate - famciclovir is indicated for the treatment of herpes zoster infection in adult patients who commence therapy within 72 hours of the onset of rash. greatest benefit occurs if the drug is started within 48 hours. efficacy has not been demonstrated in patients less than 50 years of age, although the occasional younger patient with severe herpes zoster may benefit from therapy with famciclovir. herpes zoster infection is generally a milder condition in younger patients. famciclovir is also indicated for the treatment of recurrent episodes of genital herpes in adults and adolescents 12 years of age and older. famciclovir is also indicated for suppression of recurrent genital herpes. famciclovir is also indicated in immunocompromised patients for:- treatment of uncomplicated herpes zoster, - treatment of recurrent herpes simplex, - suppression of recurrent herpes simplex

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - famciclovir -

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - famciclovir -

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - famciclovir -

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - famciclovir - oral tablet - 500mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - famciclovir - oral tablet - 500mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

arrow generics ltd - famciclovir - oral tablet - 250mg